Benchmarking Trajectory Inference Methods: A Review of Metrics, Datasets, and Best Practices for Method Selection

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-20

Key Takeaways

• Method selection for trajectory inference is critically dependent on dataset dimensions (cell and gene count) and expected trajectory topology (linear, branched, cyclic), as demonstrated by the 2019 Nature Biotechnology benchmark, which found no single method universally superior.
• Preprocessing choices, including feature selection and dimension reduction, significantly impact trajectory inference performance, necessitating dataset-specific evaluation rather than relying solely on general benchmark rankings, as highlighted by the Escort framework.
• Robustness to preprocessing variations and computational scalability are crucial performance dimensions, especially for large single-cell datasets, as methods with excellent accuracy on small datasets may be impractical for high-throughput analyses.
• Benchmarking studies emphasize the importance of validating trajectory inference results across multiple methods and considering complementary tools, as different algorithms excel at reconstructing distinct trajectory shapes and capturing specific biological dynamics.
• Understanding common failure patterns, such as the inability to reconstruct complex topologies, sensitivity to preprocessing, and distortion by doublets, is essential for interpreting trajectory inference results and avoiding overinterpretation of pseudotime as a direct measure of biological time.

Trajectory inference methods reconstruct cellular developmental paths from single-cell omics data, but method performance varies substantially across dataset dimensions, topology, and preprocessing choices. Published benchmarks provide the evidence base for method selection, yet interpreting their results requires understanding the metrics used, the datasets evaluated, and the limitations of each comparison framework. This article reviews the major benchmarking studies of trajectory inference methods, explains the evaluation metrics and dataset designs they employ, and translates their findings into practical guidance for researchers working with single-cell RNA sequencing, single-nucleus RNA sequencing, and related omics data.

The Method Selection Problem in Trajectory Inference

Single-cell RNA sequencing experiments profile thousands to millions of individual cells, capturing snapshots of gene expression that reflect underlying biological processes such as development, differentiation, and disease progression. Trajectory inference methods computationally order these cells along developmental paths, reconstructing the dynamic processes that static measurements cannot directly reveal. The challenge is that more than 70 trajectory inference tools have been developed, and they vary substantially in the input data they require and the output models they produce. This diversity makes direct comparison difficult because a method designed for one data type or trajectory topology may perform poorly on another.

Researchers face a practical decision problem. They must choose a method before understanding how well it will perform on their specific dataset. The choice affects downstream interpretations, including which genes are identified as dynamically regulated, which cell states are considered transitional, and which branch points are deemed biologically meaningful. Published benchmarks address this problem by systematically comparing methods under controlled conditions, but the results are only useful if researchers understand how to interpret them for their own data.

The benchmarking literature has grown alongside the development of trajectory inference methods themselves. Early comparisons focused on accuracy and scalability. More recent studies examine how preprocessing decisions, such as feature selection and dimension reduction, interact with method performance. The most useful benchmarks provide rankings and guidance on when specific methods are appropriate based on dataset characteristics.

At a Glance: Benchmark Evidence for Method Selection

The table below summarizes the major benchmarking studies covered in this article, their scope, and the practical guidance they offer for method selection.

Core Principles of Trajectory Inference Benchmarking

Benchmarking trajectory inference methods requires defining what constitutes good performance. Unlike classification tasks with clear ground truth labels, trajectory inference involves reconstructing continuous structures from noisy high-dimensional data. The evaluation must therefore consider multiple aspects of performance simultaneously.

Cellular Ordering Accuracy

The most fundamental metric in trajectory inference benchmarking is whether the method correctly orders cells along the true developmental path. For datasets with known ground truth, such as synthetic data generated from simulated trajectories or real data with experimentally validated cell states, benchmarks can measure how well the inferred pseudotime matches the expected ordering. The 2019 Nature Biotechnology benchmark of 45 trajectory inference methods on 110 real and 229 synthetic datasets evaluated cellular ordering as one of its primary performance dimensions. The study found that method performance depended heavily on dataset dimensions and trajectory topology, meaning that no single method dominated across all conditions.

Topology Reconstruction

Trajectory inference methods must also correctly identify the structure of the developmental process. Some datasets follow a simple linear path from one cell state to another. Others contain branches, where a progenitor cell differentiates into multiple distinct cell types. Still others contain cycles, such as the cell cycle, where cells return to their starting state. Methods vary in their ability to reconstruct these different topologies. The 2019 benchmark highlighted the complementarity of existing tools, with different methods excelling at different trajectory shapes. Researchers should therefore consider the expected topology of their biological system when selecting a method.

Scalability and Computational Efficiency

Single-cell datasets have grown from thousands to millions of cells, and trajectory inference methods must handle this scale. The 2019 benchmark evaluated scalability as a distinct performance dimension, recognizing that a method with excellent accuracy on small datasets may be impractical for large ones. Computational efficiency matters for practical workflow decisions. Researchers with limited computing resources may need to prioritize methods that can process their data within available time and memory constraints. The benchmark's freely available data and evaluation pipeline at https://benchmark.dynverse.org allows researchers to assess methods under conditions similar to their own data.

Robustness to Preprocessing Choices

Trajectory inference methods do not operate in isolation. They receive input data that has been processed through quality control, normalization, feature selection, and dimension reduction steps. The 2024 Briefings in Bioinformatics study on data-driven selection of analysis decisions found that trajectory method performance is highly dataset-specific and that even universal data processing steps such as feature selection and dimension reduction affect outcomes. This finding has important implications for benchmarking interpretation. A method that performs well in a benchmark using one preprocessing pipeline may perform differently when applied to data processed through an alternative pipeline.

Major Benchmarking Studies and Their Findings

The trajectory inference benchmarking literature includes several landmark studies that provide the evidence base for method selection. Each study has distinct strengths and limitations that researchers should understand before applying their conclusions.

The Comprehensive 2019 Nature Biotechnology Benchmark

The most widely cited benchmark of trajectory inference methods compared 45 methods on 110 real and 229 synthetic datasets. This study evaluated methods across four dimensions: cellular ordering, topology, scalability, and usability. The results demonstrated that the choice of method should depend mostly on dataset dimensions and trajectory topology. The study also produced a set of guidelines to help users select the best method for their dataset, and the evaluation pipeline remains freely available for researchers who want to assess methods under conditions matching their own data.

The scale of this benchmark is notable. The inclusion of both real and synthetic datasets allows for different types of evaluation. Real datasets provide biological relevance but have uncertain ground truth. Synthetic datasets have known ground truth but may not capture all the complexities of real biological data. The combination of both types provides a more complete picture of method performance than either alone.

The Escort Framework for Data-Driven Method Selection

The 2024 Briefings in Bioinformatics study introduced Escort, a framework for evaluating a dataset's suitability for trajectory inference and quantifying trajectory properties influenced by analysis decisions. Escort addresses a gap in the benchmarking literature by focusing on the interaction between dataset characteristics and method performance. Instead of providing a single recommendation, Escort evaluates whether trajectory analysis is appropriate for a given dataset and assesses the combined effects of processing choices using trajectory-specific metrics.

Escort is implemented as an R package and R/Shiny application, making it accessible to researchers who want to apply data-driven assessments to their own trajectory analysis. The framework reduces uncertainty and decision burden by providing quantitative assessments of how processing choices affect trajectory inference outcomes. This approach recognizes that method selection is not a one-time decision but an ongoing process that should be informed by data characteristics.

The BEELINE Framework for Gene Regulatory Network Inference

While not exclusively focused on trajectory inference, the BEELINE framework from the 2020 Nature Methods study provides relevant benchmarking evidence. BEELINE evaluates algorithms for inferring gene regulatory networks from single-cell transcriptomic data, using synthetic networks with predictable trajectories, literature-curated Boolean models, and diverse transcriptional regulatory networks. The study found that techniques that do not require pseudotime-ordered cells are generally more accurate, which has implications for trajectory inference workflows that depend on accurate pseudotime as input to downstream analyses.

The BEELINE study also found that the area under the precision-recall curve and early precision of the algorithms were moderate, indicating that gene regulatory network inference from single-cell data remains challenging. The algorithms performed better on synthetic networks than on Boolean models, and the methods with the best early precision values for Boolean models also performed well on experimental datasets. These findings suggest that researchers should validate network inference results across multiple methods and datasets.

Benchmarking of Related Single-Cell Analysis Steps

Trajectory inference does not operate in isolation. It depends on upstream steps such as doublet detection and quality control, and it feeds into downstream analyses such as gene regulatory network inference and cell fate prediction. Benchmarking studies of these related steps provide context for interpreting trajectory inference results.

The 2021 Cell Systems benchmark of doublet-detection methods evaluated nine methods on 16 real datasets with experimentally annotated doublets and 112 realistic synthetic datasets. The study found that existing methods exhibited diverse performance and distinct advantages in different aspects. DoubletFinder had the best detection accuracy, while cxds had the highest computational efficiency. Doublet detection matters for trajectory inference because doublets appear to be real cells but are not, and they can distort inferred trajectories.

The 2022 Genome Biology study on integrating temporal single-cell gene expression modalities benchmarked ten integration approaches on ten datasets spanning different biological contexts, sequencing technologies, and species. The study found that integrated data more accurately infers biological trajectories and achieves increased performance on classifying cells according to perturbation and disease states. Simple concatenation of spliced and unspliced molecules performed consistently well on classification tasks and could be used over more memory-intensive and computationally expensive methods.

Metrics Used in Trajectory Inference Benchmarks

Understanding the metrics used in benchmarking studies is essential for interpreting their results. Different metrics capture different aspects of performance, and a method that excels on one metric may perform poorly on another.

Accuracy Metrics

Accuracy metrics measure how well the inferred trajectory matches the true trajectory. For datasets with known ground truth, benchmarks can calculate the correlation between inferred pseudotime and true pseudotime, the agreement between inferred and true topology, and the precision of branch point identification. The 2019 Nature Biotechnology benchmark evaluated cellular ordering as a primary metric, measuring how well methods ordered cells along the true developmental path.

Accuracy metrics have limitations. They require ground truth, which is rarely available for real biological datasets. Synthetic datasets provide ground truth but may not capture all the complexities of real data. The 2020 Nature Methods BEELINE study addressed this challenge by using multiple types of ground truth, including synthetic networks, Boolean models, and experimental datasets, to provide a more complete picture of method performance.

Scalability Metrics

Scalability metrics measure how computational requirements grow with dataset size. These metrics include runtime, memory usage, and the ability to process datasets of increasing size within reasonable time and resource constraints. The 2019 Nature Biotechnology benchmark evaluated scalability as a distinct performance dimension, recognizing that a method with excellent accuracy may be impractical for large datasets.

Scalability is particularly important for researchers working with large single-cell datasets. The 2023 Annual Review of Biomedical Data Science study on computational methods for single-cell proteomics noted that advances in single-cell technologies have resulted in high-dimensional datasets comprising millions of cells. Trajectory inference methods must be able to handle this scale to be useful in practice.

Robustness Metrics

Robustness metrics measure how stable method performance is across different conditions. These conditions include variations in preprocessing choices, dataset characteristics, and parameter settings. The 2024 Briefings in Bioinformatics Escort study focused specifically on this aspect, evaluating how trajectory method performance is affected by analysis decisions such as feature selection and dimension reduction.

Robustness is important because researchers rarely know the optimal preprocessing choices for their data in advance. A method that performs well under a narrow range of conditions may be less useful than a method that performs adequately across a wide range of conditions. The Escort framework provides a way to assess this aspect of performance for specific datasets.

Usability Metrics

Usability metrics measure how easy a method is to use, including documentation quality, ease of installation, availability of tutorials, and compatibility with standard analysis workflows. The 2019 Nature Biotechnology benchmark evaluated usability as one of its four performance dimensions. Usability matters for practical adoption because researchers are more likely to use methods that are well-documented and integrate smoothly into existing workflows.

The Galaxy Training Network at https://training.galaxyproject.org/ provides accessible workflow training and analysis tutorials that can help researchers learn how to use trajectory inference methods. The Bioconductor project at https://bioconductor.org/ provides official package, workflow, installation, and reproducible genomic-analysis documentation for many trajectory inference methods implemented in R.

Dataset Design in Trajectory Inference Benchmarks

The datasets used in benchmarking studies determine the generalizability of their findings. Understanding dataset design helps researchers assess whether benchmark results apply to their own data.

Synthetic Datasets

Synthetic datasets are generated by simulating gene expression data from known trajectories. They have the advantage of known ground truth, allowing precise measurement of accuracy metrics. The 2019 Nature Biotechnology benchmark included 229 synthetic datasets, providing a large and diverse set of test conditions.

Synthetic datasets have limitations. They may not capture all the complexities of real biological data, including technical noise, batch effects, and biological variability. The 2020 Nature Methods BEELINE study developed a strategy to simulate single-cell transcriptional data from synthetic and Boolean networks that avoids pitfalls of previously used methods, addressing some of these limitations.

Real Datasets

Real datasets are generated from actual biological samples. They have the advantage of biological relevance but the disadvantage of uncertain ground truth. The 2019 Nature Biotechnology benchmark included 110 real datasets, providing a substantial test set for evaluating method performance under realistic conditions.

Real datasets are particularly valuable for evaluating whether methods perform well on data with the characteristics that researchers actually encounter. The 2021 Cell Systems doublet-detection benchmark included 16 real datasets with experimentally annotated doublets, providing ground truth for evaluating detection accuracy under realistic conditions.

Multi-Omic Datasets

Recent benchmarking studies have expanded to include multi-omic datasets that profile multiple molecular modalities from the same cells. The 2023 Nature Methods SCENIC+ study benchmarked the method on diverse datasets from different species, including human peripheral blood mononuclear cells, ENCODE cell lines, melanoma cell states, and Drosophila retinal development. The study used SCENIC+ to study the dynamics of gene regulation along differentiation trajectories, demonstrating the value of multi-omic approaches for trajectory analysis.

The 2026 ArchVelo study introduced a computational framework for modeling gene regulation and inferring trajectories from paired single-cell chromatin accessibility and transcriptomic data. The study benchmarked ArchVelo on mouse brain and human hematopoiesis datasets and found that it outperformed existing methods in trajectory inference accuracy and gene-level latent time alignment. ArchVelo enables trajectory decomposition into archetypal components and identifies the underlying transcription factors, providing a principled framework for modeling dynamic gene regulation in multi-omic single-cell data.

Practical Workflow for Method Selection

Selecting a trajectory inference method requires a systematic approach that considers dataset characteristics, biological context, and available computational resources. The following workflow integrates evidence from benchmarking studies with practical considerations.

Step 1: Assess Dataset Characteristics

Before selecting a method, characterize the dataset in terms of dimensions, expected topology, and data quality. The 2019 Nature Biotechnology benchmark found that the choice of method should depend mostly on dataset dimensions and trajectory topology. Datasets with many cells and genes may require methods that scale efficiently. Datasets with expected branching or cyclic topologies may require methods that can reconstruct these structures.

The Escort framework from the 2024 Briefings in Bioinformatics study provides a data-driven approach to this assessment. Escort evaluates a dataset's suitability for trajectory inference and quantifies trajectory properties influenced by analysis decisions. Using Escort can help researchers determine whether trajectory analysis is appropriate for their data and which processing choices are likely to produce reliable results.

Step 2: Evaluate Preprocessing Choices

Trajectory inference methods receive input data that has been processed through quality control, normalization, feature selection, and dimension reduction. The 2024 Briefings in Bioinformatics study found that trajectory method performance is highly dataset-specific and that even universal data processing steps affect outcomes. Researchers should therefore evaluate how preprocessing choices affect their specific dataset.

The National Center for Biotechnology Information at https://www.ncbi.nlm.nih.gov/ provides access to sequence resources and analysis services that can support preprocessing and quality assessment. The Bioconductor project at https://bioconductor.org/ provides official package documentation for many preprocessing tools implemented in R.

Step 3: Select Candidate Methods Based on Benchmark Evidence

Use benchmarking results to identify candidate methods appropriate for the dataset characteristics. The 2019 Nature Biotechnology benchmark provides guidelines for method selection based on dataset dimensions and trajectory topology. The benchmark's evaluation pipeline at https://benchmark.dynverse.org allows researchers to assess methods under conditions similar to their own data.

Consider the complementarity of existing tools highlighted by the benchmark. Different methods excel at different trajectory shapes and dataset characteristics. Selecting multiple methods with complementary strengths can provide a more complete picture than relying on a single method.

Step 4: Validate Results Across Methods

Run multiple candidate methods on the dataset and compare their results. The 2020 Nature Methods BEELINE study found that techniques that do not require pseudotime-ordered cells are generally more accurate for gene regulatory network inference. This finding suggests that trajectory inference results should be validated using methods that do not depend on the same assumptions.

The 2022 Genome Biology study on integrating temporal single-cell gene expression modalities found that integrated data more accurately infers biological trajectories. Simple concatenation of spliced and unspliced molecules performed consistently well on classification tasks. Researchers should consider whether integrating temporal modalities could improve their trajectory inference results.

Step 5: Document and Report Decisions

Record the methods used, preprocessing choices, parameter settings, and validation results. The nf-core documentation at https://nf-co.re/docs provides community pipeline standards for reproducible workflow configuration. The Carpentries lessons at https://carpentries.org/lessons provide foundational training in computing, data, shell, Git, and programming that supports reproducible analysis practices.

Documentation is essential for reproducibility and for interpreting results in the context of the analysis decisions that produced them. The 2024 Briefings in Bioinformatics study emphasized that trajectory method performance is highly dataset-specific, meaning that results cannot be interpreted without understanding the processing choices that preceded them.

Records and Measurements for Trajectory Inference

Maintaining detailed records of trajectory inference analyses supports reproducibility and enables informed method selection for future analyses. The following measurements should be recorded for each trajectory inference run.

Data Quality Metrics

Record quality control metrics for the input data, including the number of cells, number of genes, distribution of read counts, and proportion of cells passing quality filters. The 2021 Cell Systems doublet-detection benchmark found that doublets are a key confounder in scRNA-seq data analysis. Recording doublet detection results and the method used for detection provides context for interpreting trajectory inference results.

Preprocessing Parameters

Record all preprocessing choices, including normalization method, feature selection approach, number of features selected, dimension reduction method, and number of dimensions retained. The 2024 Briefings in Bioinformatics study found that these choices significantly affect trajectory method performance. Recording them allows results to be interpreted in the context of the processing decisions that produced them.

Method Parameters

Record the trajectory inference method used, its version, and all parameter settings. The 2019 Nature Biotechnology benchmark found that method performance depends on dataset dimensions and trajectory topology. Recording method parameters allows results to be compared across datasets and analyses.

Performance Metrics

Record runtime, memory usage, and any quality metrics provided by the method. The 2019 Nature Biotechnology benchmark evaluated scalability as a distinct performance dimension. Recording computational requirements helps researchers plan future analyses and select methods appropriate for their computing resources.

Validation Results

Record the results of any validation analyses, including comparisons across methods and assessments of result stability. The 2020 Nature Methods BEELINE study found that the area under the precision-recall curve and early precision of gene regulatory network inference algorithms were moderate. Recording validation results provides evidence for the reliability of trajectory inference conclusions.

Common Failure Patterns in Trajectory Inference

Understanding common failure patterns helps researchers identify problems in their trajectory inference analyses and interpret results appropriately.

Failure to Reconstruct Complex Topologies

Trajectory inference methods vary in their ability to reconstruct different topologies. The 2019 Nature Biotechnology benchmark found that method performance depends on trajectory topology, with different methods excelling at different shapes. Methods that perform well on linear trajectories may fail on branching or cyclic trajectories. Researchers should select methods appropriate for the expected topology of their biological system.

Sensitivity to Preprocessing Choices

The 2024 Briefings in Bioinformatics study found that trajectory method performance is highly dataset-specific and that even universal data processing steps such as feature selection and dimension reduction affect outcomes. Methods that perform well with one preprocessing pipeline may perform poorly with another. Researchers should evaluate how preprocessing choices affect their specific dataset instead of assuming that a method will perform consistently across conditions.

Distortion by Doublets and Artifacts

The 2021 Cell Systems doublet-detection benchmark found that doublets appear to be real cells but are not, and they are a key confounder in scRNA-seq data analysis. Doublets can distort inferred trajectories by creating spurious cell states or connections. Researchers should perform doublet detection before trajectory inference and consider how remaining doublets might affect results.

Overinterpretation of Pseudotime

Pseudotime is an inferred ordering of cells along a developmental path, not a direct measurement of time. The 2023 Annual Review of Biomedical Data Science study on computational methods for single-cell proteomics noted that advances in single-cell technologies have resulted in high-dimensional datasets capable of answering key questions about biology and disease. However, pseudotime inference relies on assumptions about the relationship between gene expression and developmental progression. Researchers should interpret pseudotime as a computational construct that may or may not correspond to actual temporal dynamics.

Inappropriate Method Selection

Selecting a method without considering dataset characteristics can lead to poor results. The 2019 Nature Biotechnology benchmark found that the choice of method should depend mostly on dataset dimensions and trajectory topology. Researchers who select methods without considering these factors may obtain suboptimal results. The benchmark's guidelines and evaluation pipeline provide evidence-based support for method selection.

Limitations of Current Benchmarking Evidence

The benchmarking literature provides valuable evidence for method selection, but it has limitations that researchers should understand.

Limited Coverage of Method Space

The 2019 Nature Biotechnology benchmark evaluated 45 methods, but more than 70 trajectory inference tools have been developed. Methods developed after the benchmark was published are not included in its comparisons. Researchers should check whether newer methods have been evaluated in subsequent benchmarks or whether they need to conduct their own comparisons.

Dataset-Specific Findings

The 2024 Briefings in Bioinformatics study found that trajectory method performance is highly dataset-specific. Benchmark results may not generalize to datasets with different characteristics. Researchers should use benchmarks as a starting point for method selection but should validate results on their own data.

Rapidly Evolving Method Landscape

Trajectory inference methods continue to be developed and improved. The 2026 LAIOR study introduced a hyperbolic neural ODE variational framework for interpretable single-cell manifold learning and trajectory inference, benchmarking it across 118 single-cell datasets against 23 baseline methods on 22 complementary metrics. The 2026 multiHIVE study introduced a hierarchical multimodal deep generative model for inferring integrated cellular embeddings of multimodal data. These newer methods may not be included in earlier benchmarks.

Ground Truth Uncertainty

Real datasets have uncertain ground truth, making it difficult to evaluate accuracy metrics. The 2019 Nature Biotechnology benchmark included both real and synthetic datasets to address this limitation, but the uncertainty of real dataset ground truth remains a challenge for interpreting benchmark results.

Professional Escalation Criteria

Researchers should escalate trajectory inference concerns to appropriate professionals when they encounter situations that require specialized expertise.

When to Consult a Bioinformatics Core

Consult a bioinformatics core or computational biology specialist when the dataset has unusual characteristics that may require specialized methods. These characteristics include very large datasets, multi-omic data, or data from non-model organisms. The 2023 Nature Methods SCENIC+ study demonstrated the value of multi-omic approaches for trajectory analysis, but these approaches require specialized expertise to implement and interpret.

When to Consult a Statistics Expert

Consult a statistics expert when the trajectory inference results are unstable across methods or parameter settings. The 2024 Briefings in Bioinformatics study found that trajectory method performance is highly dataset-specific and that processing choices significantly affect outcomes. A statistics expert can help design validation analyses and interpret results in the context of uncertainty.

When to Consult a Domain Expert

Consult a domain expert in the biological system being studied when trajectory inference results conflict with established biological knowledge. The 2019 Nature Biotechnology benchmark found that different methods excel at different trajectory shapes. A domain expert can help assess whether inferred trajectories are biologically plausible and whether discrepancies between methods reflect biological complexity or methodological artifacts.

When to Consult a Computing Professional

Consult a computing professional when computational requirements exceed available resources. The 2019 Nature Biotechnology benchmark evaluated scalability as a distinct performance dimension, recognizing that some methods are impractical for large datasets. A computing professional can help optimize computational workflows or identify alternative methods with lower resource requirements.

A Practical Decision Framework for Trajectory Inference Method Selection

Benchmarking studies provide rankings and general guidance, but translating their findings into a concrete method choice for a specific dataset requires a structured decision process. The following framework operationalizes the evidence from published benchmarks into a repeatable workflow that researchers can apply before committing computational resources to a particular method.

Step 1: Score Dataset Dimensions Against Benchmark Conditions

The 2019 Nature Biotechnology benchmark of 45 trajectory inference methods on 110 real and 229 synthetic datasets found that method choice should depend mostly on dataset dimensions and trajectory topology. Begin by recording three quantitative characteristics of your dataset: cell count, gene count after quality filtering, and expected trajectory complexity.

For cell count, classify the dataset as small under 5,000 cells, medium between 5,000 and 50,000 cells, or large above 50,000 cells. For gene count, note whether you are working with full transcriptome data, targeted panels, or dimensionality-reduced representations. For topology, record whether the expected developmental process is linear, branched, cyclic, or disconnected.

The 2024 Briefings in Bioinformatics study on the Escort framework demonstrated that trajectory method performance is highly dataset-specific, meaning that even universal data processing steps such as feature selection and dimension reduction affect outcomes. This finding implies that dataset dimensions alone do not determine method choice. The interaction between dimensions and preprocessing choices matters, and the Escort framework provides a quantitative way to assess this interaction for a specific dataset.

Step 2: Evaluate Topology Expectations Against Method Capabilities

The 2019 benchmark highlighted the complementarity of existing tools, with different methods excelling at different trajectory shapes. Before selecting a method, document the expected topology based on prior biological knowledge. For example, hematopoietic differentiation typically involves branching topologies, while cell cycle studies involve cyclic topologies.

For datasets where topology is unknown, run an initial exploratory analysis using a method that handles multiple topology types. The benchmark's evaluation pipeline at https://benchmark.dynverse.org allows researchers to assess methods under conditions similar to their own data, which can help identify methods that reconstruct the topology most consistent with biological expectations.

Step 3: Assess Preprocessing Sensitivity Before Method Selection

The 2024 Briefings in Bioinformatics study found that trajectory method performance is highly dataset-specific and that even universal data processing steps such as feature selection and dimension reduction affect outcomes. This finding has a practical implication: method selection should occur after preprocessing decisions, not before.

Run the candidate method on the same dataset processed through two or three different preprocessing pipelines. Compare the resulting trajectories for stability. If the trajectory structure changes substantially across preprocessing choices, the method is sensitive to preprocessing and results should be interpreted with caution. The Escort framework, implemented as an R package and R/Shiny application, provides trajectory-specific metrics for quantifying how processing choices affect outcomes.

Step 4: Apply the Benchmark Decision Rules

The 2019 Nature Biotechnology benchmark produced a set of guidelines to help users select the best method for their dataset. These guidelines are based on the finding that method choice should depend mostly on dataset dimensions and trajectory topology. Apply the following decision rules derived from the benchmark findings:

For small datasets with linear topology, prioritize methods with high cellular ordering accuracy. For large datasets, prioritize methods with demonstrated scalability, as the benchmark evaluated scalability as a distinct performance dimension. For datasets with branching topology, select methods that the benchmark identified as performing well on branched trajectories. For datasets with unknown topology, select methods that handle multiple topology types and validate results across methods.

Step 5: Validate With Complementary Methods

The 2020 Nature Methods BEELINE study found that techniques that do not require pseudotime-ordered cells are generally more accurate for gene regulatory network inference. This finding suggests that trajectory inference results should be validated using methods with different underlying assumptions.

Run at least two methods with different algorithmic approaches on the same dataset. Compare the inferred trajectories, focusing on which cell states are identified as transitional and which branch points are deemed biologically meaningful. The 2022 Genome Biology study on integrating temporal single-cell gene expression modalities found that integrated data more accurately infers biological trajectories, so consider whether incorporating spliced and unspliced molecule information could improve validation.

Step 6: Document the Decision Trail

Record the dataset characteristics, topology expectations, preprocessing choices, candidate methods, and validation results. The nf-core documentation at https://nf-co.re/docs provides community pipeline standards for reproducible workflow configuration that can support this documentation process. The Carpentries lessons at https://carpentries.org/lessons provide foundational training in computing and data practices that support reproducible analysis.

Documentation is essential because the 2024 Briefings in Bioinformatics study emphasized that trajectory method performance is highly dataset-specific. Results cannot be interpreted without understanding the processing choices that preceded them, and future analyses will benefit from knowing which methods and parameters produced reliable results on similar data.

A Record System for Trajectory Inference Method Comparisons

Maintaining structured records of method comparisons enables evidence-based method selection for future analyses and supports reproducibility. The following record system captures the information needed to interpret benchmark results in the context of a specific dataset.

Dataset Characterization Record

Record the number of cells, number of genes, sequencing platform, species, tissue type, and expected biological process. Include quality control metrics such as the proportion of cells passing filters and doublet detection results. The 2021 Cell Systems doublet-detection benchmark found that doublets are a key confounder in scRNA-seq data analysis, so recording doublet detection results provides essential context for interpreting trajectory inference outcomes.

Preprocessing Pipeline Record

Record the normalization method, feature selection approach, number of features selected, dimension reduction method, and number of dimensions retained. The 2024 Briefings in Bioinformatics study found that these choices significantly affect trajectory method performance. Include software versions for all tools used in the preprocessing pipeline.

Method Comparison Record

For each candidate method, record the version, parameter settings, runtime, memory usage, and any quality metrics provided by the method. The 2019 Nature Biotechnology benchmark evaluated scalability as a distinct performance dimension, so recording computational requirements helps researchers plan future analyses and select methods appropriate for their computing resources.

Validation Record

Record the results of cross-method comparisons, including which cell states were consistently identified as transitional across methods and which branch points were consistently identified. Record any discrepancies between methods and the biological interpretation of those discrepancies. The 2020 Nature Methods BEELINE study found that the area under the precision-recall curve and early precision of gene regulatory network inference algorithms were moderate, suggesting that validation across methods is particularly important for downstream analyses.

Troubleshooting Method Selection Failures

When trajectory inference results are unsatisfactory, the following troubleshooting approach can identify whether the problem lies in method selection, preprocessing, or data quality.

Problem: Methods Produce Inconsistent Trajectories

If different methods produce substantially different trajectories, first check whether the dataset is suitable for trajectory inference. The Escort framework from the 2024 Briefings in Bioinformatics study evaluates a dataset's suitability for trajectory inference and quantifies trajectory properties influenced by analysis decisions. If the dataset is not suitable, trajectory inference may not be appropriate regardless of method choice.

If the dataset is suitable, examine whether preprocessing choices are driving the inconsistency. Run the same method on the same data processed through different preprocessing pipelines. If trajectories change substantially across preprocessing choices, the inconsistency may reflect preprocessing sensitivity instead of method differences.

Problem: Inferred Trajectories Conflict With Known Biology

If inferred trajectories conflict with established biological knowledge, consult a domain expert in the biological system being studied. The 2019 Nature Biotechnology benchmark found that different methods excel at different trajectory shapes, so a trajectory that conflicts with known biology may reflect a method that is poorly suited to the expected topology.

Consider whether the dataset contains artifacts that could distort trajectories. The 2021 Cell Systems doublet-detection benchmark found that doublets appear to be real cells but are not, and they are a key confounder in scRNA-seq data analysis. Re-examine doublet detection results and consider whether remaining doublets could create spurious cell states or connections.

Problem: Computational Requirements Exceed Available Resources

If a method with good benchmark performance is computationally impractical for the dataset, consult a computing professional to optimize the computational workflow or identify alternative methods with lower resource requirements. The 2019 Nature Biotechnology benchmark evaluated scalability as a distinct performance dimension, recognizing that some methods are impractical for large datasets.

Consider whether dimensionality reduction before trajectory inference could reduce computational requirements. The 2024 Briefings in Bioinformatics study found that dimension reduction significantly affects trajectory method performance, so any dimensionality reduction should be evaluated for its effect on trajectory quality.

Problem: Results Are Unstable Across Parameter Settings

If trajectory results change substantially across parameter settings, the method may be sensitive to parameter choices. The 2024 Briefings in Bioinformatics study found that trajectory method performance is highly dataset-specific, and parameter sensitivity is one aspect of this dataset specificity.

Run the method with a range of parameter values and record how the trajectory structure changes. If the trajectory is stable across a reasonable range of parameter values, results can be interpreted with confidence. If the trajectory changes substantially, consider whether the method is appropriate for the dataset or whether an alternative method with lower parameter sensitivity would be more reliable.

Welfare and Reproducibility Context

Trajectory inference results inform biological interpretations that can affect downstream research decisions, including which genes are prioritized for functional validation and which cell states are considered biologically meaningful. The 2023 Annual Review of Biomedical Data Science study on computational methods for single-cell proteomics noted that advances in single-cell technologies have resulted in high-dimensional datasets capable of answering key questions about biology and disease. The reliability of trajectory inference directly affects the reliability of these answers.

Reproducibility practices support the validity of trajectory inference results. The nf-core documentation at https://nf-co.re/docs provides community pipeline standards for reproducible workflow configuration. The Galaxy Training Network at https://training.galaxyproject.org/ provides accessible workflow training and analysis tutorials. The Bioconductor project at https://bioconductor.org/ provides official package, workflow, installation, and reproducible genomic-analysis documentation for many trajectory inference methods implemented in R.

The National Center for Biotechnology Information at https://www.ncbi.nlm.nih.gov/ provides access to sequence resources and analysis services that support data management and quality assessment. The Carpentries lessons at https://carpentries.org/lessons provide foundational training in computing, data, shell, Git, and programming that supports reproducible analysis practices.

Researchers should document all method selection decisions, preprocessing choices, parameter settings, and validation results. This documentation supports interpretation of results in the context of the analysis decisions that produced them and enables future analyses to build on evidence from previous method comparisons.

Frequently Asked Questions

What is the difference between trajectory inference and pseudotime analysis?

Trajectory inference reconstructs the structure of cellular developmental paths, including branches and cycles, while pseudotime analysis orders cells along a single developmental path. Trajectory inference methods typically produce both a trajectory structure and pseudotime values for individual cells. The 2019 Nature Biotechnology benchmark evaluated both cellular ordering and topology as distinct performance dimensions, recognizing that these are related but separate aspects of method performance.

How do I choose between trajectory inference methods for my dataset?

The 2019 Nature Biotechnology benchmark found that the choice of method should depend mostly on dataset dimensions and trajectory topology. Consider the number of cells and genes in your dataset, the expected structure of the developmental process, and your available computational resources. The benchmark's evaluation pipeline at https://benchmark.dynverse.org allows you to assess methods under conditions similar to your own data.

What preprocessing steps are most important before trajectory inference?

The 2024 Briefings in Bioinformatics study found that even universal data processing steps such as feature selection and dimension reduction significantly affect trajectory method performance. Quality control to remove low-quality cells and doublet detection to remove artifacts are also important. The 2021 Cell Systems doublet-detection benchmark found that doublets are a key confounder in scRNA-seq data analysis.

How do I validate trajectory inference results?

Validate results by running multiple methods and comparing their outputs, assessing the stability of results across parameter settings, and checking whether inferred trajectories are consistent with known biology. The 2020 Nature Methods BEELINE study found that techniques that do not require pseudotime-ordered cells are generally more accurate for gene regulatory network inference, suggesting that validation should include methods with different assumptions.

What are the limitations of synthetic datasets in benchmarking?

Synthetic datasets have known ground truth, allowing precise measurement of accuracy metrics, but they may not capture all the complexities of real biological data. The 2019 Nature Biotechnology benchmark included both real and synthetic datasets to address this limitation. The 2020 Nature Methods BEELINE study developed a strategy to simulate single-cell transcriptional data that avoids pitfalls of previously used methods.

How do multi-omic approaches affect trajectory inference?

Multi-omic approaches that profile multiple molecular modalities from the same cells can improve trajectory inference by providing complementary information. The 2023 Nature Methods SCENIC+ study used multi-omic data to study the dynamics of gene regulation along differentiation trajectories. The 2026 ArchVelo study introduced a framework for modeling gene regulation and inferring trajectories from paired chromatin accessibility and transcriptomic data.

What should I do if different methods produce different trajectories?

Different methods can produce different trajectories because they make different assumptions about the relationship between gene expression and developmental progression. The 2019 Nature Biotechnology benchmark found that different methods excel at different trajectory shapes. Compare results across methods, assess which results are consistent with known biology, and consider consulting a domain expert to interpret discrepancies.

How do I report trajectory inference methods in publications?

Report the specific method and version used, all parameter settings, preprocessing choices, and validation results. The nf-core documentation at https://nf-co.re/docs provides community pipeline standards for reproducible workflow configuration. The Carpentries lessons at https://carpentries.org/lessons provide foundational training in computing and data practices that support reproducible analysis.

Related Bioinformatics Guides

• Benchmarking Atlas-Level Data Integration in Single-Cell Genomics: Methods and Best Practices
• Radiomics Feature Selection: Methods and Best Practices
• Longitudinal Microbiome Data Analysis: Methods and Best Practices
• Spatial Transcriptomics Differential Expression: Methods and Best Practices
• Metagenomic Contamination Control: Best Practices for Clean Data

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

• NCBI Data Resources. National Center for Biotechnology Information.
• Bioconductor. Bioconductor Project.
• Galaxy Training Network. Galaxy Project.
• nf-core Documentation. nf-core.
• The Carpentries Lessons. The Carpentries.
• A comparison of single-cell trajectory inference methods.. Nature biotechnology, 2019.
• Benchmarking Computational Doublet-Detection Methods for Single-Cell RNA Sequencing Data.. Cell systems, 2021.
• SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks.. Nature methods, 2023.
• Benchmarking algorithms for gene regulatory network inference from single-cell transcriptomic data.. Nature methods, 2020.
• Integrating computational pathology and multi-transcriptomics to characterize lung adenocarcinoma heterogeneity and prognostic modeling.. International journal of surgery (London, England), 2025.
• Computational Methods for Single-Cell Proteomics.. Annual review of biomedical data science, 2023.
• Data-driven selection of analysis decisions in single-cell RNA-seq trajectory inference.. Briefings in bioinformatics, 2024.
• Data-driven selection of analysis decisions in single-cell RNA-seq trajectory inference.. bioRxiv : the preprint server for biology, 2023.
• LAIOR: a hyperbolic neural ODE variational framework for interpretable single-cell manifold learning and trajectory inference.. 2026.
• multiHIVE: Hierarchical Multimodal Deep Generative Modeling for Single-cell Multiomics. 2026.
• scCCVGBen for benchmarking of single-cell representation learning anchored on a centroid-coupled variational graph attention autoencoder across scRNA-seq and scATAC-seq.. 2026.
• Computational blueprints for cell fate programming.. 2026.
• ArchVelo: archetypal velocity modeling for single-cell multi-omic trajectories.. 2026.
• Histology-informed spatial domain identification through multi-view graph convolutional networks.. 2026.
• TIVelo: RNA velocity estimation leveraging cluster-level trajectory inference. Nature Communications, 2025.
• Integrating temporal single-cell gene expression modalities for trajectory inference and disease prediction. Genome Biology, 2022.
• A robust and accurate single-cell data trajectory inference method using ensemble pseudotime. BMC Bioinformatics, 2023.
• Recent advances in trajectory inference from single-cell omics data. Current Opinion in Systems Biology, 2021.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.